Shawn mcCormick - 01 May 2025 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
Director
Signature
/s/ Bryan Phillips, Attorney-in-Fact for Shawn T McCormick
Issuer symbol
INSP
Transactions as of
01 May 2025
Net transactions value
-$57,600
Form type
4
Filing time
05 May 2025, 19:31:25 UTC
Previous filing
03 Apr 2025
Next filing
06 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
mcCormick Shawn Director C/O INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY /s/ Bryan Phillips, Attorney-in-Fact for Shawn T McCormick 05 May 2025 0001454092

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Award $0 +1,266 +5.5% $0.000000 24,406 01 May 2025 Direct F1
transaction INSP Common Stock Sale $57,600 -360 -1.5% $160.00 24,046 02 May 2025 Direct
holding INSP Common Stock 3,000 01 May 2025 By trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.

Remarks:

All sales reported herein were made pursuant to a Rule 10b5-1 trading plan dated November 13, 2024.